TITLE

Risk of depression in patients with chronic obstructive pulmonary disease and its determinants

AUTHOR(S)
van Manen, J. G.; Bindels, P. J. E.; Dekker, F. W.; Ijzermans, C. J.; van der Zee, J. S.; Schadé, E.
PUB. DATE
May 2002
SOURCE
Thorax;May2002, Vol. 57 Issue 5, p412
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Although it has been repeatedly suggested that chronic obstructive pulmonary disease (COPD) is associated with depression, no conclusion has so far been reached. A study was undertaken to investigate whether depression occurs more often in patients with COPD than in controls. The demographic and clinical variables associated with depression were also determined. Methods: Patients with a registered diagnosis of obstructive airway disease in general practice, aged ⩾40 years, forced expiratory volume in 1 second (FEV1) <80% predicted, FEV1 reversibility ⩽ 12%, FEV1/VC⩽ predicted - 1 .64 × SD, and a history of smoking were selected. A random sample of subjects without a registered diagnosis of asthma or COPD aged 40 years or older acted as controls. Depression was assessed using the Centers for Epidemiologic Studies Depression (CES-D) scale. Results: In patients with severe COPD (FEV1 <50% predicted), the prevalence of depression was 25.0% compared with 17.5% in controls and 19.6% in patients with mild to moderate COPD. When the results were adjusted for demographic variables and comorbidity, the risk for depression was 2.5 times greater for patients with severe COPD than for controls (OR 2.5, 95% CI 1.2 to 5.4). In patients with mild to moderate COPD this increased risk of depression was not seen. Living alone, reversibility of FEV1 % predicted, respiratory symptoms and physical impairment were significantly associated with the scores on the CES-D scale. Conclusion: Patients with severe COPD are at increased risk of developing depression. The results of this study underscore the importance of reducing symptoms and improving physical functioning in patients with COPD.
ACCESSION #
12980761

 

Related Articles

  • How asthma care is changing. Hall, Julie // Independent Nurse;8/4/2008, p27 

    The article features the recent innovations for the treatment of asthma in Great Britain. One of the recently made innovations includes the chloroflurocarbon (CFC)-containing preventers which require half-dose reduction due to particle size and are available as a breath-actuated product....

  • Depression, Anxiety, and COPD: The Unexamined Role of Nicotine Dependence. Goodwin, Renee D.; Lavoie, Kim L.; Lemeshow, Adina R.; Jenkins, Elizabeth; Brown, E. Sherwood; Fedoronko, David A. // Nicotine & Tobacco Research;Feb2012, Vol. 14 Issue 2, p176 

    Introduction: Previous studies have shown links between anxiety and depression and chronic obstructive pulmonary disease (COPD), but little is known about possible mechanisms of this association. The current study examined whether the observed relationship between anxiety and depression and COPD...

  • The Possible Association Of Staphylococcus Enterotoxin B As A Cause Of Asthma In The Presence Of Sinusitis. Yang, Ping-Chang; Liu, Tao; Kong, Wei-Jia; Wang, Bin-Quan // Internet Journal of Ophthalmology & Visual Science;2006, Vol. 4 Issue 2, p40 

    The prevalence of asthma is increasing in the world. The pathogenesis needs to be further understood. Asthma is closely related with sinusitis, but the detailed mechanisms are yet not clear. Eighty-five patients with sinusitis and asthma underwent functional endoscopic sinus surgical treatment...

  • Circadian and concentration profile of cathepsin S in sera from healthy subjects and asthmatic patients. Cimerman, Nina; Brguljan, Pika Meško; Krašovec, Marta; Šuškovič, Stanislav; Kos, Janko // Pflugers Archiv European Journal of Physiology;Sep2001, Vol. 442 Issue 7, pr204 

    Cathepsin S (CS) has been proposed to be associated with asthma pathogenesis but its exact role is not established. In order to understand this proposed association our objective was to follow the 24-h concentration pattern of CS in sera from apparently healthy subjects and from...

  • Mid-expiratory flow versus FEY1 measurements in the diagnosis of exercise induced asthma in elite athletes. Dickinson, J. W.; Whyte, G. P.; McConnell, A. K.; Nevill, A. M.; Harries, M. G. // Thorax;Feb2006, Vol. 61 Issue 2, p111 

    Backround: A fall in FEV1 of ⩾10% following bronchoprovocation (eucapnic voluntary hyperventilation (EVH) or exercise) is regarded as the gold standard criterion for diagnosing exercise induced asthma (EIA) in athletes. Previous studies have suggested that mid-expiratory flow (FEF50) might...

  • Combined budesonide and formoterol for maintenance and relief provided better asthma control than budesonide for maintenance and terbutaline for relief. Rabe, K. F.; Pizzichini, E.; Ställberg, B. // Evidence Based Medicine;Oct2006, Vol. 11 Issue 5, p138 

    The article presents a study on the effectiveness of the combination of budesonide and formoterol in treating patients with mild to moderate asthma. The result showed that budesonide and formoterol in a single inhaler was more effective than a higher dose of budesonide for maintenance plus...

  • Leukotriene Receptor Antagonists for the Treatment of Asthma in Elderly Patients. Trinh, Hoang; Ban, Ga-Young; Lee, Ji-Ho; Park, Hae-Sim // Drugs & Aging;Oct2016, Vol. 33 Issue 10, p699 

    Elderly asthma (EA) is regarded as a distinct phenotype of asthma and is associated with age-related changes in airway structure and alterations in lung function and immune responses. EA is difficult to diagnose because of aging and co-morbidities, and overlaps with fixed airway obstructive...

  • Screening for Depression Disorders in Patients with Chronic Somatic Illness. Filipčić, Igor; Popović-Grle, Sanja; Marčnko, Darko; Basšić, Silvio; Hotujac, Ljubomir; Pavičić, Fadila; Hajnšeka, Sanja; Aganović, Izet // Collegium Antropologicum;Mar2007, Vol. 31 Issue 1, p139 

    Depression is one of the most common complications in patients with chronic somatic illnesses. Comorbidity of depression with physical illness often remains unrecognized and untreated, additionally aggravating the somatic illness itself its treatment and prognosis. The aim of this study was to...

  • Chronic Obstructive Pulmonary Disease in Women: Past and Future Challenges. Han, MeiLan K.; DeMeo, Dawn L.; Mannino, David M.; Ohar, Jill A. // Journal of Women's Health (15409996);2014Supplement-COPD in Women An Expert Panel Discussion, p1 

    The article discusses the highlights of a panel discussion which discussed practical suggestions for clinicians treating women with chronic obstructive pulmonary disease (COPD). Participants in the panel were Doctor (Dr.) Dawn DeMeo, Dr. David M Mannino and Dr. Jill A. Ohar who covered topics...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics